Federal contract award
HDTRA120C0016
PHARMACOLOGICAL AND BIOLOGIC INTERVENTION TO REDUCE INFLAMMATION AND SEIZURES CAUSED BY VIRAL ENCEPHALITIS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | DEFENSE THREAT REDUCTION AGENCY |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AD93 — OTHER DEFENSE - ADVANCED DEVELOPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $1.2M |
| Current contract value | $1.2M |
| Potential contract value / ceiling | $1.2M |
| Start date | Jun 15, 2020 |
| Current end date | Jun 14, 2025 |
| Potential end date | Jun 14, 2025 |
| Latest award activity | May 12, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 12, 2025 | P00010 | $0 | REDUCE INFLAMMATION AND SEIZURES CAUSED BY VIRAL ENCEPHALITIS |
| Mar 19, 2025 | P00009 | $0 | PHARMACOLOGICAL AND BIOLOGIC INTERVENTION TO REDUCE INFLAMMATION AND SEIZURES CAUSED BY ENCEPHALITIS |
| Feb 6, 2025 | P00008 | $244.8K | PHARMACOLOGICAL AND BIOLOGIC INTERVENTION TO REDUCE INFLAMMATION AND SEIZURES CAUSED BY ENCEPHALITIS. |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.